After the passage of health care legislation by the House last night, we speculated that traders would dump health care stocks in a panic and we would have the opportunity to buy them on the dip. We cited money managers such as BlackRock's Bob Doll who said that health care stocks were cheap. We expected that the sentiment of people like republican congressman Paul Broun from Georgia, who said that health care reform would "destroy America," would be the prevailing one among traders.
We were wrong -- completely and utterly wrong.
As the headline in the Wall Street Journal said, health care ETFs gained on the passage of the reform bill. Apparently, investors like Doll weren't the only ones who felt that while there would be pressure on margins, the addition of 32 million additional customers will yield higher profits. ETFs focusing on pharmaceutical stocks were up, with gains among major ETFs in this sector ranging from 1.4 to 1.8 percent on the day. And biotech ETFs also gained, although the gains were smaller. Those were up by around 0.8 percent. Hospitals, who will gain because they will see fewer patients who do not have insurance, increased by 1.6 percent.
The only segment of the health insurance industry that didn't participate in the gains was the insurance industry. These stocks were down by about 0.1 percent. Here, investors are concerned that while they will get more customers, these customers will not be the kinds of clients they want. Also, their ability to shed unprofitable customers will be lost and that is a concern as well.
Still, though, traders agreed that health care stocks will for the most part benefit from the reforms that passed yesterday. And their initial reaction casts a lot of doubt on the contention of those who claim it will destroy America.
We were wrong -- completely and utterly wrong.
As the headline in the Wall Street Journal said, health care ETFs gained on the passage of the reform bill. Apparently, investors like Doll weren't the only ones who felt that while there would be pressure on margins, the addition of 32 million additional customers will yield higher profits. ETFs focusing on pharmaceutical stocks were up, with gains among major ETFs in this sector ranging from 1.4 to 1.8 percent on the day. And biotech ETFs also gained, although the gains were smaller. Those were up by around 0.8 percent. Hospitals, who will gain because they will see fewer patients who do not have insurance, increased by 1.6 percent.
The only segment of the health insurance industry that didn't participate in the gains was the insurance industry. These stocks were down by about 0.1 percent. Here, investors are concerned that while they will get more customers, these customers will not be the kinds of clients they want. Also, their ability to shed unprofitable customers will be lost and that is a concern as well.
Still, though, traders agreed that health care stocks will for the most part benefit from the reforms that passed yesterday. And their initial reaction casts a lot of doubt on the contention of those who claim it will destroy America.
![Reblog this post [with Zemanta]](http://img.zemanta.com/reblog_e.png?x-id=2be84268-7b37-48cb-8d0e-2f282b1a529d)


![Reblog this post [with Zemanta]](http://img.zemanta.com/reblog_e.png?x-id=e3740a2a-8ab2-4dc8-97e1-4cb4ca613b35)

![Reblog this post [with Zemanta]](http://img.zemanta.com/reblog_e.png?x-id=74850960-0bef-4ec6-b75b-4f819e353839)

![Reblog this post [with Zemanta]](http://img.zemanta.com/reblog_e.png?x-id=fd0b3ef8-a8af-4e2a-8580-867b190275d8)
![Reblog this post [with Zemanta]](http://img.zemanta.com/reblog_e.png?x-id=1f18f853-37f3-484d-8430-dec160452fd0)

![Reblog this post [with Zemanta]](http://img.zemanta.com/reblog_e.png?x-id=63e2043e-4c21-4e67-a227-54a8ed71778f)
![Reblog this post [with Zemanta]](http://img.zemanta.com/reblog_e.png?x-id=eeab877c-1dfb-418d-92f9-26962980d066)
![Reblog this post [with Zemanta]](http://img.zemanta.com/reblog_e.png?x-id=35e03a14-6932-464e-a205-7ef3de9cc637)
